Polish Patients’ Needs and Opinions about the Implementation of Pharmaceutical Care in Diabetes
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. The Survey Questionnaire and Procedure
2.3. Data Analysis
3. Results
3.1. Participants’ Characteristics
3.2. Patients’ Knowledge of Diabetes and Its Prevention
3.3. Patients’ Opinions on Pharmaceutical Care Services with Particular Emphasis on Diabetology
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Ahmad, A.; Alkharfy, K.M.; Alrabiah, Z.; Alhossan, A. Saudi Arabia, pharmacists and COVID-19 pandemic. J. Pharm. Policy Pract. 2020, 13, 41. [Google Scholar] [CrossRef] [PubMed]
- Todd, A.; Copeland, A.; Husband, A.; Kasim, A.; Bambra, C. The positive pharmacy care law: An area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England. BMJ Open 2014, 4, e005764. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tsuyuki, R.T.; Beahm, N.P.; Okada, H.; Al Hamarneh, Y.N. Pharmacists as accessible primary health care providers: Review of the evidence. Can. Pharm. J./Rev. Pharm. Can. 2018, 151, 4–5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ustawa z dnia 10 Grudnia 2020 r. o Zawodzie Farmaceuty [The Act of December 10, 2020 on Pharmacist’s Profession]. Available online: https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20210000097 (accessed on 2 January 2023).
- Zespół ds. Opieki Farmaceutycznej Powołany Przez Ministra Zdrowia. Raport—Opieka Farmaceutyczna. Kompleksowa analiza Procesu Wdrożenia. Available online: https://www.nia.org.pl/2021/04/06/ministerstwo-zdrowia-przedstawia-dokument-raport-opieka-farmaceutyczna-kompleksowa-analiza-procesu-wdrozenia/ (accessed on 2 January 2023).
- Anderson, C. Pharmaceutical Care, Health Promotion, and Disease Prevention. In The Pharmacist Guide to Implementing Pharmaceutical Care; Springer International Publishing: Cham, Switzerland, 2019; pp. 287–293. [Google Scholar]
- Abdulrhim, S.; Sankaralingam, S.; Ibrahim, M.I.M.; Awaisu, A. The impact of pharmacist care on diabetes outcomes in primary care settings: An umbrella review of published systematic reviews. Prim. Care Diabetes 2020, 14, 393–400. [Google Scholar] [CrossRef] [PubMed]
- Dalton, K.; Byrne, S. Role of the pharmacist in reducing healthcare costs: Current insights. Integr. Pharm. Res. Pract. 2017, 6, 37–46. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fiłon, J. Cukrzyca—Wyzwanie Zdrowia Publicznego W XXI W. Available online: http://pbc.biaman.pl/Content/60948/Cukrzyca_wyzwanie_zdrowia_publicznego_w_XXI_w.pdf (accessed on 2 January 2023).
- World Health Organization. Global Report on Diabetes. Available online: https://www.who.int/publications/i/item/9789241565257 (accessed on 2 January 2023).
- International Diabetes Federation (IDF). The IDF Diabetes Atlas. 8th ed. Available online: http://fmdiabetes.org/wp-content/uploads/2018/03/IDF-2017.pdf (accessed on 2 January 2023).
- Forouhi, N.G.; Wareham, N.J. Epidemiology of diabetes. Medicine 2014, 42, 698–702. [Google Scholar] [CrossRef] [Green Version]
- CDC National Diabetes Statistics Report 2020. Estimates of Diabetes and Its Burden in the United States. Available online: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf (accessed on 2 January 2023).
- Towpik, I.; Walicka, M.; Marcinkowska, K.; Lisicka, I.; Raczyńska, M.; Wierzba, W.; Strojek, K.; Ryś, P.; Wajda-Cuszlag, M.; Franek, E. Epidemiology of diabetes in Poland in 2014–2017. Clin. Diabetol. 2020, 9, 279–285. [Google Scholar] [CrossRef]
- Knowler, W.C.; Barrett-Connor, E.; Fowler, S.E.; Hamman, R.F.; Lachin, J.M.; Walker, E.A.; Nathan, D.M. Diabetes Prevention Program Research Group Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. N. Engl. J. Med. 2002, 346, 393–403. [Google Scholar] [CrossRef]
- Zalecenia Kliniczne Dotyczące Postępowania u Chorych na Cukrzycę 2022. Stanowisko Polskiego Towarzystwa Diabetologicznego. Available online: https://ptdiab.pl/images/docs/zalecenia/CTiD-1-2022-pl.pdf (accessed on 2 January 2023).
- Lipka, M.; Kończalska, K.; Kędziora-Kornatowska, K. Diabetes—Diagnosis, treatment, complications and rehabilitation. J. Educ. Health Sport 2020, 10, 322–331. [Google Scholar] [CrossRef]
- Schultz, J.L.; Horner, K.E.; McDanel, D.L.; Miller, M.L.; Beranek, R.L.; Jacobsen, R.B.; Sly, N.J.; Miller, A.C.; Mascardo, L.A. Comparing Clinical Outcomes of a Pharmacist-Managed Diabetes Clinic to Usual Physician-Based Care. J. Pharm. Pract. 2018, 31, 268–271. [Google Scholar] [CrossRef]
- Adibe, M.O.; Ukwe, C.V.; Aguwa, C.N. The Impact of Pharmaceutical Care Intervention on the Quality of Life of Nigerian Patients Receiving Treatment for Type 2 Diabetes. Value Health Reg. Issues 2013, 2, 240–247. [Google Scholar] [CrossRef] [PubMed]
- Khaira, M.; Mathers, A.; Benny Gerard, N.; Dolovich, L. The Evolving Role and Impact of Integrating Pharmacists into Primary Care Teams: Experience from Ontario, Canada. Pharmacy 2020, 8, 234. [Google Scholar] [CrossRef]
- Inch, J.; Avenell, A.; Aucott, L.; Watson, M.C. A mixed-methods evaluation of a community pharmacy signposting service to a commercial weight-loss provider. Public Health Nutr. 2018, 21, 2311–2319. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- European Directorate for the Quality of Medicines & HealthCare. Pharmaceutical care—Policies and Practices for a Safer, More Responsible and Cost-Effective Health System; European Directorate for the Quality of Medicines & HealthCare: Strasbourg, France, 2012. [Google Scholar]
- Jasińska, M.; Kurczewska, U.; Orszulak-Michalak, D. Zjawisko non-adherence w procesie opieki farmaceutycznej. Farm. Pol. 2009, 65, 765–771. [Google Scholar]
- Hughes, J.; Wibowo, Y.; Sunderland, B.; Hoti, K. The role of the pharmacist in the management of type 2 diabetes: Current insights and future directions. Integr. Pharm. Res. Pract. 2017, 6, 15–27. [Google Scholar] [CrossRef] [Green Version]
- Siaw, M.Y.L.; Ko, Y.; Malone, D.C.; Tsou, K.Y.K.; Lew, Y.-J.; Foo, D.; Tan, E.; Chan, S.C.; Chia, A.; Sinaram, S.S.; et al. Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): A randomized controlled trial. J. Clin. Pharm. Ther. 2017, 42, 475–482. [Google Scholar] [CrossRef] [Green Version]
- Presser, S.; Couper, M.P.; Lessler, J.T.; Martin, E.; Martin, J.; Rothgeb, J.M.; Singer, E. Methods for Testing and Evaluating Survey Questions. Public Opin. Q. 2004, 68, 109–130. [Google Scholar] [CrossRef] [Green Version]
- Skowron, A.; Polak, S.; Brandys, J. The impact of pharmaceutical care on patients with hypertension and their pharmacists. Pharm. Pract. 2011, 9, 110–115. [Google Scholar] [CrossRef] [Green Version]
- Khan, M.U.; Khan, A.N.; Ahmed, F.R.; Feroz, Z.; Rizvi, S.A.; Shah, S.; Hussain, R.; Adil, Z. Patients’ opinion of pharmacists and their roles in health care system in Pakistan. J. Young Pharm. 2013, 5, 90–94. [Google Scholar] [CrossRef] [Green Version]
- Boehme, M.W.J.; Buechele, G.; Frankenhauser-Mannuss, J.; Mueller, J.; Lump, D.; Boehm, B.O.; Rothenbacher, D. Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany—a retrospective cohort and case control study in claims data of a large statutory health insurance. BMC Public Health 2015, 15, 855. [Google Scholar] [CrossRef] [Green Version]
- NFZ o Zdrowiu. Polipragmazja. Available online: https://www.nia.org.pl/wp-content/uploads/2020/02/Raport-polipragmazja.pdf (accessed on 2 January 2023).
- Hepler, C.D.; Strand, L.M. Opportunities and responsibilities in pharmaceutical care. Am. J. Hosp. Pharm. 1990, 47, 533–543. [Google Scholar] [CrossRef] [PubMed]
- Najafzadeh, M.; Schnipper, J.; Shrank, W.; Kymes, S.; Brennan, T.; Choudhry, N. Economic value of pharmacist-led medication reconciliation for reducing medication errors after hospital discharge. Am. J. Manag. Care 2016, 22, 654–661. [Google Scholar] [PubMed]
- Wrzosek, N.; Chlebowska, A.; Polakowska, D.; Miszewska, J.; Kowalska, S.; Dobbek, O.; Zimmermann, A. Examination of the need for additional pharmaceutical services and selected elements of pharmaceutical care in Poland—Pilot study. Farm. Pol. 2021, 77, 271–280. [Google Scholar] [CrossRef]
- Cardosi, L.; Hohmeier, K.C.; Fisher, C.; Wasson, M. Patient Satisfaction With a Comprehensive Medication Review Provided by a Community Pharmacist. J. Pharm. Technol. 2018, 34, 48–53. [Google Scholar] [CrossRef] [PubMed]
- Salvo, M.C.; Cannon-Breland, M.L. Motivational interviewing for medication adherence. J. Am. Pharm. Assoc. 2015, 55, e354–e363. [Google Scholar] [CrossRef] [PubMed]
- USP Zdrowie 2018. Raport: Jak Wprowadzić w Polsce Opiekę Farmaceutyczną. Available online: https://www2.deloitte.com/pl/pl/pages/life-sciences-and-healthcare/articles/raport-jak-wprowadzic-w-polsce-opieke-farmaceutyczna.html (accessed on 2 January 2023).
- NFZ o Zdrowiu. Cukrzyca. Available online: https://szkolpacjent.ezdrowie.gov.pl/taxonomy/term/85/jak-zyc-z-cukrzyca (accessed on 2 January 2023).
- Hales, C.M.; Carroll, M.D.; Fryar, C.D.; Ogden, C.L. Prevalence of Obesity and Severe Obesity among Adults: United States, 2017–2018. Available online: https://www.cdc.gov/nchs/data/databriefs/db360-h.pdf (accessed on 2 January 2023).
- Główny Urząd Statystyczny w Polsce. Stan zdrowia ludności Polski w 2019 r. Available online: https://stat.gov.pl/obszary-tematyczne/zdrowie/zdrowie/stan-zdrowia-ludnosci-polski-w-2019-r-,26,1.html (accessed on 2 January 2023).
- Chau, T.K.; Fong, D.Y.T.; Chan, S.S.C.; Wong, J.Y.H.; Li, W.H.C.; Tan, K.C.B.; Leung, A.Y.M.; Wong, D.C.N.; Leung, D.Y.P.; Lam, T.H. Misconceptions about smoking in patients with type 2 diabetes mellitus: A qualitative analysis. J. Clin. Nurs. 2015, 24, 2545–2553. [Google Scholar] [CrossRef]
- Mumu, S.J.; Saleh, F.; Ara, F.; Haque, M.R.; Ali, L. Awareness regarding risk factors of type 2 diabetes among individuals attending a tertiary-care hospital in Bangladesh: A cross-sectional study. BMC Res. Notes 2014, 7, 599. [Google Scholar] [CrossRef] [Green Version]
- Nazar, C.M.J.; Bojerenu, M.M.; Safdar, M.; Marwat, J. Effectiveness of diabetes education and awareness of diabetes mellitus in combating diabetes in the United Kigdom; a literature review. J. Nephropharmacol. 2016, 5, 110–115. [Google Scholar]
- Belsti, Y.; Akalu, Y.; Fekadu, H.; Animut, Y. Awareness of complications of diabetes mellitus and its associated factors among type 2 diabetic patients at Addis Zemen District Hospital, northwest Ethiopia. BMC Res. Notes 2019, 12, 602. [Google Scholar] [CrossRef] [Green Version]
- Muninarayana, C.; Balachandra, G.; Hiremath, S.; Iyengar, K.; Anil, N. Prevalence and awareness regarding diabetes mellitus in rural Tamaka, Kolar. Int. J. Diabetes Dev. Ctries. 2010, 30, 18. [Google Scholar] [CrossRef] [Green Version]
- Bukhsh, A.; Khan, T.M.; Phisalprapa, P.; Duangjai, A.; Saokaew, S.; Nawaz, M.S.; Ahmed, H.S.; Goh, B.H. Impact of Pharmacist-Led Diabetes Self-Care Education on Patients with Type 2 Diabetes in Pakistan: A Randomized Controlled Trial. Front. Pharmacol. 2022, 13, 200. [Google Scholar] [CrossRef] [PubMed]
- Mourão, A.O.M.; Ferreira, W.R.; Martins, M.A.P.; Reis, A.M.M.; Carrillo, M.R.G.; Guimarães, A.G.; Ev, L.S. Pharmaceutical care program for type 2 diabetes patients in Brazil: A randomised controlled trial. Int. J. Clin. Pharm. 2013, 35, 79–86. [Google Scholar] [CrossRef] [PubMed]
- Colagiuri, S.; Davies, D. The value of early detection of type 2 diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 2009, 16, 95–99. [Google Scholar] [CrossRef] [PubMed]
- Bookwalter, C. Unlocking the Full Potential of Self-Monitoring of Blood Glucose. U.S. Pharm. 2019, 44, 29–32. [Google Scholar]
- Müller, U.; Hämmerlein, A.; Casper, A.; Schulz, M. Community pharmacy-based intervention to improve self-monitoring of blood glucose in type 2 diabetic patien. Pharm. Pract. 2006, 4, 195–203. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kjome, R.L.S.; Granas, A.G.; Nerhus, K.; Sandberg, S. Quality assessment of patients’ self-monitoring of blood glucose in community pharmacies. Pharm. Pract. 2010, 8, 62. [Google Scholar] [CrossRef] [Green Version]
- AlShayban, D.M.; Naqvi, A.A.; Islam, M.A.; Almaskeen, M.; Almulla, A.; Alali, M.; AlQaroos, A.; Raafat, M.; Iqbal, M.S.; Haseeb, A. Patient Satisfaction and Their Willingness to Pay for a Pharmacist Counseling Session in Hospital and Community Pharmacies in Saudi Healthcare Settings. Front. Pharmacol. 2020, 11, 138. [Google Scholar] [CrossRef] [Green Version]
- Harris, M. Challenges in diabetes management. Aust. Fam. Physician 2008, 37, 716–720. [Google Scholar]
- Choe, H.M.; Bernstein, S.J.; Mueller, B.A.; Walker, P.C.; Stevenson, J.G.; Standiford, C.J. Pharmacist leads primary care team to improve diabetes care. Am. J. Health Pharm. 2009, 66, 622–624. [Google Scholar] [CrossRef]
- Anderegg, M.D.; Gums, T.H.; Uribe, L.; MacLaughlin, E.J.; Hoehns, J.; Bazaldua, O.V.; Ives, T.J.; Hahn, D.L.; Coffey, C.S.; Carter, B.L. Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease. Pharmacother. J. Hum. Pharmacol. Drug Ther. 2018, 38, 309–318. [Google Scholar] [CrossRef]
Gender | Female | 60.3% |
Male | 39.7% | |
Age range | 18–29 | 29.0% |
30–39 | 28.2% | |
40–49 | 15.3% | |
50–59 | 14.5% | |
60–69 | 6.9% | |
70–79 | 6.1% | |
Education level | Primary | 2.3% |
Lower secondary | 1.5% | |
Secondary | 22.1% | |
Vocational | 3.8% | |
Higher | 70.2% | |
BMI [norm: 18.5–24.9] | Below the norm | 3.1% |
Within the norm | 72.5% | |
Above the norm | 24.4% | |
Diabetes in family | Yes | 55.0% |
No | 38.9% | |
I don’t know | 6.1% | |
Number of physicians attended | 1 physician | 32.8% |
2 physicians | 16.0% | |
3 physicians | 17.6% | |
4 physicians | 6.1% | |
More than 4 physicians | 4.6% | |
No physicians | 22.9% |
Questions about New Services Posed to Respondents | Patients’ Subgroups | Yes | No | I Don’t Know |
---|---|---|---|---|
Would you like a pharmacist to provide you with information on a newly prescribed drug (New Drug service)? | Family diabetes burden | 91.7% | 4.2% | 4.2% |
No family history of diabetes | 86.0% | 4.0% | 10.0% | |
p-value | p = 0.030 | |||
Would you like a pharmacist to review your medication? | Patients interested in the New Drug Service | 86.8% | 3.5% | 9.7% |
Patients not interested in the New Drug Service | 20.0% | 60.0% | 20.0% | |
Patients with no opinion | 27.3% | 0.0% | 72.7% | |
p-value | p < 0.001 | |||
Would you like a pharmacist to review your medication? | Family diabetes burden | 86.1% | 4.2% | 9.7% |
No family history of diabetes | 76.0% | 6.0% | 18.0% | |
p-value | p = 0.024 |
Questions about New Services Posed to Respondents | Patients’ Subgroups | Yes | No | I Don’t Know |
---|---|---|---|---|
Would you like the pharmacist to educate you in the use of the glucose meter? | Patients believing that diabetes prevention is important | 97.3% | 88.9% | 80.0% |
Patients with no opinion on the prevention of diabetes | 2.7% | 11.1% | 20.0% | |
p-value | p = 0.028 | |||
Would you like the pharmacist to educate you on insulin administration/lancing device operation? | Patients interested in a drug review | 85.8% | 60.0% | 40.0% |
Patients not interested in a drug review | 3.6% | 40.0% | 6.7% | |
Patients with no opinion | 10.9% | 0.0% | 53.3% | |
p-value | p < 0.001 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Waszyk-Nowaczyk, M.; Guzenda, W.; Kamasa, K.; Zielińska-Tomczak, Ł.; Cerbin-Koczorowska, M.; Michalak, M.; Przymuszała, P.; Plewka, B. Polish Patients’ Needs and Opinions about the Implementation of Pharmaceutical Care in Diabetes. Int. J. Environ. Res. Public Health 2023, 20, 945. https://doi.org/10.3390/ijerph20020945
Waszyk-Nowaczyk M, Guzenda W, Kamasa K, Zielińska-Tomczak Ł, Cerbin-Koczorowska M, Michalak M, Przymuszała P, Plewka B. Polish Patients’ Needs and Opinions about the Implementation of Pharmaceutical Care in Diabetes. International Journal of Environmental Research and Public Health. 2023; 20(2):945. https://doi.org/10.3390/ijerph20020945
Chicago/Turabian StyleWaszyk-Nowaczyk, Magdalena, Weronika Guzenda, Karolina Kamasa, Łucja Zielińska-Tomczak, Magdalena Cerbin-Koczorowska, Michał Michalak, Piotr Przymuszała, and Beata Plewka. 2023. "Polish Patients’ Needs and Opinions about the Implementation of Pharmaceutical Care in Diabetes" International Journal of Environmental Research and Public Health 20, no. 2: 945. https://doi.org/10.3390/ijerph20020945